|
|
 |
|
Viewing report
|
|
|
|
Clinical Trials in Poland 2008. Development Forecasts for 2008-2010
PMR Ltd, June 2008, Pages: 141
Clinical trials in Poland 2008 is the second edition of our research of the sector and thus it offers you a unique opportunity to keep track of market trends and developments over the last several years. It provides a comprehensive study of the sector, with data on its value and development prospects.
Based on our recent research and exclusive interviews with experts in the field, the report reveals the attitudes of managers of pharmaceutical companies and CROs towards the market, and situates Poland’s clinical trials in the context of other Central and Eastern European countries.
Key Facts
- Legislative work on the Clinical Trials Law is underway.
- International CROs’ interest in the CEE market is increasing.
- Patient recruitment in CEE is smooth and speedy.
- Inspection carried out by the FDA confirms high quality of clinical trials conducted in Poland.
- 449 trials were registered in Poland in 2007.
A database of over 60 CROs active on the Polish market is added to the report as a supplement, containing the following information:
- company name
- address
- website
- e-mail
- fax number
- telephone number.
Clinical trials in Poland 2008 will be particularly useful to:
- Clinical Research Organisations (CROs) and pharmaceutical companies interested in launching operations in Poland or cooperating with their Polish counterparts pharmaceutical companies
CROs keen to keep track of Poland’s clinical trials market other companies active on the Polish clinical trials market, such as Site Management Organisations (SMOs)
- or companies interested in providing medical equipment and clinical trial materials decision makers who need to gain a thorough understanding of the key trends on the market.
A Word from the Authors
“Poland is one of the largest markets for clinical trials in Central and Eastern Europe. Despite certain administrative and legal obstacles, Poland's share in the entire clinical trails market has been fairly high and stable for several years. Well aware of insufficient availability of detailed information on the market, we decided to deliver our second report providing companies operating in the sector with complete picture of the clinical trails industry. Our analysis is a unique study based on a research carried out among a representative sample of pharmaceutical companies and CROs operating in Poland”.
Monika Stefanczyk, Senior Pharmaceutical Analyst
Agnieszka Stawarska, Pharmaceutical Analyst
This title is also available in the following language
Clinical Trials in Poland 2008. Development Forecasts for 2008-2010 (Polish Version)
Customers who bought this item also bought
Clinical Trials in Poland 2008. Development Forecasts for 2008-2010
Clinical Trials in Russia 2008. Russia Compared to Other Countries
Clinical Trials in India
Booming Clinical Trials Market in India
Streamlining Clinical Trials
Conducting Clinical Trials in Emerging Markets
Industry Insight Clinical Trials in India
Innovations and Trends in Clinical Trials - Microdosing (Phase 0 Trials), Adaptive Trials, Phase IV Trials and the Role of Information Technology
State of the Clinical Trials Industry, 2009
Central and Eastern Europe: Outsourcing Trends and Growth Opportunities in Clinical Trials
Outsourcing Clinical Trials: A Global Analytical Guide and Comparative Analysis of International Destinations, with Location Attractiveness Index
European E-Clinical Trials Markets
|
|
|
|
